According to Meridian Bioscience's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.47072. At the end of 2022 the company had a P/S ratio of 4.14.
Year | P/S ratio | Change |
---|---|---|
2022 | 4.14 | 46.2% |
2021 | 2.83 | 5.16% |
2020 | 2.69 | 26.81% |
2019 | 2.12 | -38.72% |
2018 | 3.47 | 20.71% |
2017 | 2.87 | -24.75% |
2016 | 3.82 | -14.2% |
2015 | 4.45 | 24.45% |
2014 | 3.57 | -39% |
2013 | 5.86 | 24.78% |
2012 | 4.70 | -1.67% |
2011 | 4.78 | -30.64% |
2010 | 6.88 | 23.1% |
2009 | 5.59 | -23.7% |
2008 | 7.33 | -21.91% |
2007 | 9.39 | 63.73% |
2006 | 5.73 | 8.19% |
2005 | 5.30 | 59.02% |
2004 | 3.33 | 46.17% |
2003 | 2.28 | 39.14% |
2002 | 1.64 | 2.16% |
2001 | 1.60 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 5.12 | 14.47% | ๐บ๐ธ USA |
Becton Dickinson BDX | 3.47 | -22.30% | ๐บ๐ธ USA |
Hologic HOLX | 4.56 | 2.10% | ๐บ๐ธ USA |
QuidelOrtho QDEL | 0.9013 | -79.84% | ๐บ๐ธ USA |